Get started
Author

Nicolas Picard

Observed names: N Picard, N. Picard, PICARD, Nicolas, Picard N, Picard Nicolas, Picard, Nicolas
Observed institutions: Oslo University Hospital, Cliniques Universitaires Saint-Luc, Inserm, University of California, San Francisco, University of Oslo, Erasmus MC, University Hospital Heidelberg, Centre Hospitalier Universitaire de Lille, Hospital Clínic de Barcelona, Centre Hospitalier Universitaire de Limoges, Hôpital Universitaire Dupuytren, Hospital Central de las Fuerzas Armadas, Klinikum Stuttgart, Hôpital de la Timone, Hôpital Paul-Brousse, Pharmacologie & Transplantation, Ciblage individuel et prévention des risques de traitements immunosupresseurs et de la transplantation, University of Colorado Anschutz, Université Lille Nord de France, Université de Limoges, Universitat de Barcelona, Assiut University, UCLouvain
ORCID: 0000-0001-8460-903X
Observed ORCID: 0000-0001-8460-903X
OpenAlex ID: A5040564590
Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus Report
2019 · Mercè Brunet, Teun van Gelder, et al. · Therapeutic Drug Monitoring · 713
Is inappropriate medication use a major cause of adverse drug reactions in the elderly?
2006 · Marie‐Laure Laroche, Jean‐Pierre Charmes, et al. · British Journal of Clinical Pharmacology · 318
PDF
Identification of the Udp-glucuronosyltransferase Isoforms Involved in Mycophenolic Acid Phase Ii Metabolism
2004 · Nicolas Picard, Damrong Ratanasavanh, et al. · Drug Metabolism and Disposition · 282
The Role of Organic Anion–Transporting Polypeptides and Their Common Genetic Variants in Mycophenolic Acid Pharmacokinetics
2009 · N Picard, S W Yee, et al. · Clinical Pharmacology & Therapeutics · 167
In Vitro Metabolism Study of Buprenorphine: Evidence for New Metabolic Pathways
2005 · Nicolas Picard, Thierry Cresteil, et al. · Drug Metabolism and Disposition · 150
Therapeutic Drug Monitoring of Everolimus
2016 · Maria Shipkova, Dennis A. Hesselink, et al. · Therapeutic Drug Monitoring · 139
Tacrolimus Population Pharmacokinetic-Pharmacogenetic Analysis and Bayesian Estimation in Renal Transplant Recipients
2009 · Khaled Benkali, Aurelie Prémaud, et al. · Clinical Pharmacokinetics · 138
UGT 1A1 genotype and irinotecan therapy: general review and implementation in routine practice
2015 · Marie‐Christine Etienne‐Grimaldi, Jean‐Christophe Boyer, et al. · Fundamental and Clinical Pharmacology · 114
Dépistage du déficit en dihydropyrimidine déshydrogénase (DPD) et sécurisation des chimiothérapies à base de fluoropyrimidines : mise au point et recommandations nationales du GPCO-Unicancer et du RNPGx
2018 · Marie-Anne Loriot, Joseph Ciccolini, et al. · Bulletin du Cancer · 108
PDF
Barcelona Consensus on Biomarker-Based Immunosuppressive Drugs Management in Solid Organ Transplantation
2016 · Mercè Brunet, Maria Shipkova, et al. · Therapeutic Drug Monitoring · 99
Contribution of the Different UDP-Glucuronosyltransferase (UGT) Isoforms to Buprenorphine and Norbuprenorphine Metabolism and Relationship with the Main UGT Polymorphisms in a Bank of Human Liver Microsomes
2009 · Koukeb Rouguieg, Nicolas Picard, et al. · Drug Metabolism and Disposition · 97
CYP3A5 Genotype Does Not Influence Everolimus In Vitro Metabolism and Clinical Pharmacokinetics in Renal Transplant Recipients
2011 · Nicolas Picard, Koukeb Rouguieg-Malki, et al. · Transplantation · 91
Involvement of UDP-Glucuronosyltransferases UGT1A9 and UGT2B7 in Ethanol Glucuronidation, and Interactions with Common Drugs of Abuse
2012 · Alaa Al Saabi, Delphine Allorge, et al. · Drug Metabolism and Disposition · 82
Donor P-gp Polymorphisms Strongly Influence Renal Function and Graft Loss in a Cohort of Renal Transplant Recipients on Cyclosporine Therapy in a Long-Term Follow-Up
2010 · J-B Woillard, J-P Rerolle, et al. · Clinical Pharmacology & Therapeutics · 79
Influence of the UGT2B7 promoter region and exon 2 polymorphisms and comedications on Acyl-MPAG production in vitro and in adult renal transplant patients
2007 · Nassim Djebli, Nicolas Picard, et al. · Pharmacogenetics and Genomics · 79
Pharmacogenetic Biomarkers Predictive of the Pharmacokinetics and Pharmacodynamics of Immunosuppressive Drugs
2015 · Nicolas Picard, Stein Bergan, et al. · Therapeutic Drug Monitoring · 75
Characterization of a Phase 1 Metabolite of Mycophenolic Acid Produced by CYP3A4/5
2004 · Nicolas Picard, Thierry Cresteil, et al. · Therapeutic Drug Monitoring · 72
Pharmacogenetics-based personalized therapy: Levels of evidence and recommendations from the French Network of Pharmacogenetics (RNPGx)
2017 · Nicolas Picard, Jean-Christophe Boyer, et al. · Therapies · 66
Polymorphisms in type I and II inosine monophosphate dehydrogenase genes and association with clinical outcome in patients on mycophenolate mofetil
2010 · Olivier Gensburger, Ron H.N. Van Schaik, et al. · Pharmacogenetics and Genomics · 60
General unknown screening procedure for the characterization of human drug metabolites in forensic toxicology: Applications and constraints
2009 · François‐Ludovic Sauvage, Nicolas Picard, et al. · Journal of Separation Science · 57
A comparison of the effect of ciclosporin and sirolimus on the pharmokinetics of mycophenolate in renal transplant patients
2006 · Nicolas Picard, Aurélie Prémaud, et al. · British Journal of Clinical Pharmacology · 49
PDF
Determination of Mycophenolic Acid Plasma Levels in Renal Transplant Recipients Co-administered Sirolimus: Comparison of an Enzyme Multiplied Immunoassay Technique (EMIT) and Liquid Chromatography–Tandem Mass Spectrometry
2006 · Aurélie Prémaud, Annick Rousseau, et al. · Therapeutic Drug Monitoring · 47
Characterization and identification of eight designer benzodiazepine metabolites by incubation with human liver microsomes and analysis by a triple quadrupole mass spectrometer
2017 · Souleiman El Balkhi, Maxime Chaslot, et al. · International Journal of Legal Medicine · 44
Risk of diarrhoea in a long‐term cohort of renal transplant patients given mycophenolate mofetil: the significant role of the UGT1A8*2 variant allele
2010 · Jean‐Baptiste Woillard, Jean‐Philippe Rerolle, et al. · British Journal of Clinical Pharmacology · 44
Metabolism of Sirolimus in the Presence or Absence of Cyclosporine by Genotyped Human Liver Microsomes and Recombinant Cytochromes P450 3A4 and 3A5
2006 · Nicolas Picard, Nassim Djebli, et al. · Drug Metabolism and Disposition · 44
Works count: 104
Citation count: 4,094
H-index: 34
I10-index: 58
Year
Topic
Type